Stenting for renal-artery stenosis [3]

New England Journal of Medicine

Volumn 370, Issue 19, 2014, Pages 1853-

  Leesar, Massoud ^a   White, Christopher ^b   De Bruyne, Bernard ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b OCHSNER MEDICAL CENTER   (United States)

^c CARDIOVASCULAR CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; PAPAVERINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ARTERY SURGERY; FRACTIONAL FLOW RESERVE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; LETTER; MEASUREMENT ACCURACY; OUTCOME ASSESSMENT; PRESSURE GRADIENT; PRIORITY JOURNAL; RENAL ARTERY STENTING; TREATMENT INDICATION; TREATMENT OUTCOME; FEMALE; MALE; NOTE; STENT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; FEMALE; HUMANS; MALE; RENAL ARTERY OBSTRUCTION; STENTS;

EID: 84899876312     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1402687     Document Type: Letter

References (3)

1. Mitchell JA, Subramanian R, White CJ, et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement: renal fractional flow reserve. Catheter Cardiovasc Interv 2007;69:685-9. (Pubitemid 46581257)
2. Mangiacapra F, Trana C, Sarno G, et al. Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension. Circ Cardiovasc Interv 2010;3:537-42.
3. Leesar MA, Varma J, Shapira A, et al. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol 2009;53:2363-71.